ARBs CORONA II, NCT04606563: Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? |
|
|
| Terminated | 3 | 341 | Europe, Canada | Losartan, Cozaar, Valsartan, Diovan, Azilsartan, Edarbi, Candesartan, Atacand, Eprosartan, Teventen, Irbesartan, Avapro, Olmesartan, Olmetec, Telmisartan, Micardis | University of British Columbia, Canadian Institutes of Health Research (CIHR) | Covid19, SARS-CoV Infection | 04/22 | 04/22 | | |
| Recruiting | 3 | 400 | Europe | Palbociclib 125mg, Ibrance, PD-0332991, Standard endocrine therapy | ETOP IBCSG Partners Foundation, Pfizer | Breast Cancer Recurrent | 01/25 | 11/27 | | |
NCT05322122: Creation of Side-to-Side Compression Anastomosis Using the Magnetic Anastomosis System |
|
|
| Completed | N/A | 49 | Europe, Canada, RoW | Side-to-side anastomosis duodeno-ileostomy diversion procedure, The MAGNET System | GT Metabolic Solutions, Inc. | Obesity | 06/23 | 04/24 | | |
NCT03894228: Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry) |
|
|
| Recruiting | N/A | 1750 | Europe | | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa, Spanish Agency of Medicines and Health Products | Inflammatory Bowel Diseases, Pregnancy | 03/24 | 03/28 | | |
NCT04982146: Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei |
|
|
| Active, not recruiting | 1 | 10 | Europe | Bromelin, N-Acetylcysteine | Maimónides Biomedical Research Institute of Córdoba | Pseudomyxoma Peritonei | 05/22 | 05/23 | | |
